102 related articles for article (PubMed ID: 21536329)
1. Deletion of chromosome 20q: friend or foe?
Hasserjian RP; Dal Cin P
Leuk Res; 2011 Jul; 35(7):844-5. PubMed ID: 21536329
[No Abstract] [Full Text] [Related]
2. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
Braun T; de Botton S; Taksin AL; Park S; Beyne-Rauzy O; Coiteux V; Sapena R; Lazareth A; Leroux G; Guenda K; Cassinat B; Fontenay M; Vey N; Guerci A; Dreyfus F; Bordessoule D; Stamatoullas A; Castaigne S; Terré C; Eclache V; Fenaux P; Adès L
Leuk Res; 2011 Jul; 35(7):863-7. PubMed ID: 21396711
[TBL] [Abstract][Full Text] [Related]
3. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
[TBL] [Abstract][Full Text] [Related]
4. Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
Mullier F; Daliphard S; Garand R; Dekeyser M; Cornet Y; Luquet I; Talmant P; Richebourg S; Jamar M; Dogné JM; Chatelain C; Michaux L; Chatelain B
Ann Hematol; 2012 Feb; 91(2):203-13. PubMed ID: 21744002
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited.
Liu YC; Ito Y; Hsiao HH; Sashida G; Kodama A; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Nov; 171(1):9-16. PubMed ID: 17074585
[TBL] [Abstract][Full Text] [Related]
7. Chromosome abnormalities in myelodysplastic syndromes.
Nowell PC
Semin Oncol; 1992 Feb; 19(1):25-33. PubMed ID: 1736367
[No Abstract] [Full Text] [Related]
8. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
Galanopoulos AG; Symeonidis A; Kourakli A; Papadaki EA; Tsaftaridis P; Terpos E; Aktipi A; Roussou P; Protopappa M; Pappaioannou M; Zikos P; Speletas M; Parcharidou A; Laoutaris N; Anagnostopoulos NI; Meletis J; Pangalis GA; Zoumbos N; Viniou N;
Eur J Haematol; 2007 Jan; 78(1):89-90. PubMed ID: 17302860
[No Abstract] [Full Text] [Related]
10. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
Li T; Xue Y; Wu Y; Pan J
Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome with ider(20q) and prominent emperipolesis.
Wong E; Juneja S
Ann Hematol; 2014 Feb; 93(2):341-2. PubMed ID: 23732442
[No Abstract] [Full Text] [Related]
12. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
[TBL] [Abstract][Full Text] [Related]
13. Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20.
Mackinnon RN; Campbell LJ
Cytogenet Genome Res; 2007; 119(3-4):211-20. PubMed ID: 18253031
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-).
Li T; Xue Y; Wu Y; Pan J
Br J Haematol; 2004 May; 125(3):337-42. PubMed ID: 15086414
[TBL] [Abstract][Full Text] [Related]
16. Acquired elliptocytosis in a patient with a myelodysplastic syndrome associated with 20q deletion.
Quiroz-Cervantes KS; Juárez-Salcedo LM; Nuevo I; Guillén H; Arbeteta J; Golbano N
Br J Haematol; 2019 Apr; 185(2):206. PubMed ID: 30592294
[No Abstract] [Full Text] [Related]
17. ASXL1 gene alterations in patients with isolated 20q deletion.
Brezinova J; Sarova I; Svobodova K; Lhotska H; Ransdorfova S; Izakova S; Pavlistova L; Lizcova L; Skipalova K; Hodanova L; Markova J; Zemanova Z; Cermak J; Jonasova A; Michalova K
Neoplasma; 2019 Jul; 66(4):627-630. PubMed ID: 30868899
[TBL] [Abstract][Full Text] [Related]
18. A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes.
MacKinnon RN; Patsouris C; Chudoba I; Campbell LJ
Genes Chromosomes Cancer; 2007 Jan; 46(1):27-36. PubMed ID: 17048234
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and experimental study of two cases of myelodysplastic syndromes with double isochromosome 20q- anomaly].
Gong SL; Xue YQ; Wang JM; Han FL; Xu YQ; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):35-8. PubMed ID: 15946507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
